Human Genome Epidemiology Literature Finder
|
Records 1 - 24 (of 24 Records) |
| Query Trace: Ovarian Neoplasms and ARID1A[original query] |
|---|
| Analysis of common variations in tumor-suppressor genes on chr1p36 among Caucasian women with endometriosis. Gynecologic oncology 2012 Nov 127 (2): 398-402. Falconer Henrik, Sundqvist Johanna, Xu Hong, Vodolazkaia Alexandra, Fassbender Amelie, Kyama Cleophas, Bokor Attila, D'Hooghe Thomas |
| Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer. International journal of cancer. Journal international du cancer 2014 Aug 135 (3): 611-23. Cajuso Tatiana, Hänninen Ulrika A, Kondelin Johanna, Gylfe Alexandra E, Tanskanen Tomas, Katainen Riku, Pitkänen Esa, Ristolainen Heikki, Kaasinen Eevi, Taipale Minna, Taipale Jussi, Böhm Jan, Renkonen-Sinisalo Laura, Mecklin Jukka-Pekka, Järvinen Heikki, Tuupanen Sari, Kilpivaara Outi, Vahteristo P |
| Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer. Journal of molecular medicine (Berlin, Germany) 2016 Feb . Er Tze-Kiong, Su Yu-Fa, Wu Chun-Chieh, Chen Chih-Chieh, Wang Jing, Hsieh Tsung-Hua, Herreros-Villanueva Marta, Chen Wan-Tzu, Chen Yi-Ting, Liu Ta-Chih, Chen Hung-Sheng, Tsai Eing-M |
| CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Oct . Ayhan Ayse, Kuhn Elisabetta, Wu Ren-Chin, Ogawa Hiroshi, Bahadirli-Talbott Asli, Mao Tsui-Lien, Sugimura Haruhiko, Shih Ie-Ming, Wang Tian- |
| Mutational heterogeneity in non-serous ovarian cancers. Scientific reports 2017 Aug 7 (1): 9728. Teer Jamie K, Yoder Sean, Gjyshi Anxhela, Nicosia Santo V, Zhang Chaomei, Monteiro Alvaro N |
| Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing. Genes, chromosomes & cancer 2018 02 57 (2): 51-60. Shibuya Yusuke, Tokunaga Hideki, Saito Sakae, Shimokawa Kazurou, Katsuoka Fumiki, Bin Li, Kojima Kaname, Nagasaki Masao, Yamamoto Masayuki, Yaegashi Nobuo, Yasuda J |
| Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses. Gynecologic oncology 2018 5 150 (1): 127-135. Mueller Jennifer J, Schlappe Brooke A, Kumar Rahul, Olvera Narciso, Dao Fanny, Abu-Rustum Nadeem, Aghajanian Carol, DeLair Deborah, Hussein Yaser R, Soslow Robert A, Levine Douglas A, Weigelt Brit |
| Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Apr . Takenaka Masataka, Köbel Martin, Garsed Dale W, Fereday Sian, Pandey Ahwan, Etemadmoghadam Dariush, Hendley Joy, Kawabata Ayako, Noguchi Daito, Yanaihara Nozomu, Takahashi Hiroyuki, Kiyokawa Takako, Ikegami Masahiro, Takano Hirokuni, Isonishi Seiji, Ochiai Kazuhiko, Traficante Nadia, Gadipally Sreeja R, Semple Timothy, Vassiliadis Dane, Amarasinghe Kaushalya Christmalee, Li Jason, Mir Arnau Gisela, Okamoto Aikou, Friedlander Michael, Bowtell David D |
| Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma. Clinica chimica acta; international journal of clinical chemistry 2019 Mar 494 1-7. Su Yu-Fa, Tsai Eing-Mei, Chen Chih-Chieh, Wu Chun-Chieh, Er Tze-Kio |
| Identification of novel mutations of ovarian cancer-related genes from RNA-sequencing data for Japanese epithelial ovarian cancer patients. Endocrine journal 2019 Nov . Nagasawa Saya, Ikeda Kazuhiro, Horie-Inoue Kuniko, Sato Sho, Takeda Satoru, Hasegawa Kosei, Inoue Satos |
| An integrated molecular profile of endometrioid ovarian cancer. Gynecologic oncology 2020 3 157 (1): 55-61. Pierson William E, Peters Pamela N, Chang Matthew T, Chen Lee-May, Quigley David A, Ashworth Alan, Chapman Jocelyn |
| Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer. BMC cancer 2020 3 20 (1): 204. Eoh Kyung Jin, Kim Hye Min, Lee Jung-Yun, Kim Sunghoon, Kim Sang Wun, Kim Young Tae, Nam Eun |
| Therapeutic options for mucinous ovarian carcinoma. Gynecologic oncology 2020 Jan . Gorringe Kylie L, Cheasley Dane, Wakefield Matthew J, Ryland Georgina L, Allan Prue E, Alsop Kathryn, Amarasinghe Kaushalya C, Ananda Sumitra, Bowtell David D L, Christie Michael, Chiew Yoke-Eng, Churchman Michael, DeFazio Anna, Fereday Sian, Gilks C Blake, Gourley Charlie, Hadley Alison M, Hendley Joy, Hunter Sally M, Kaufmann Scott H, Kennedy Catherine J, Köbel Martin, Le Page Cecile, Li Jason, Lupat Richard, McNally Orla M, McAlpine Jessica N, Pyman Jan, Rowley Simone M, Salazar Carolina, Saunders Hugo, Semple Timothy, Stephens Andrew N, Thio Niko, Torres Michelle C, Traficante Nadia, Zethoven Magnus, Antill Yoland C, Campbell Ian G, Scott Clare |
| ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer. Gynecologic oncology 2021 Jul . Kuroda Yuka, Chiyoda Tatsuyuki, Kawaida Miho, Nakamura Kohei, Aimono Eriko, Yoshimura Takuma, Takahashi Mio, Saotome Keiko, Yoshihama Tomoko, Iwasa Naomi, Sakai Kensuke, Yamagami Wataru, Nishihara Hiroshi, Aoki Daisu |
| Genetic alterations and their therapeutic implications in epithelial ovarian cancer. BMC cancer 2021 5 21 (1): 499. Lapke Nina, Chen Chien-Hung, Chang Ting-Chang, Chao Angel, Lu Yen-Jung, Lai Chyong-Huey, Tan Kien Thiam, Chen Hua-Chien, Lu Hsiao-Yun, Chen Shu-J |
| Genomic Sub-Classification of Ovarian Clear Cell Carcinoma Revealed by Distinct Mutational Signatures. Cancers 2021 10 13 (20): . Oliveira Douglas V N P, Schnack Tine H, Poulsen Tim S, Christiansen Anne P, Høgdall Claus K, Høgdall Estrid |
| Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers. Annals of surgical oncology 2022 2 29 (6): 3578-3590. Huang Chi-Cheng, Tsai Yi-Fang, Liu Chun-Yu, Lien Pei-Ju, Lin Yen-Shu, Chao Ta-Chung, Feng Chin-Jung, Chen Yen-Jen, Lai Jiun-I, Phan Nam Nhut, Hsu Chih-Yi, Chiu Jen-Hwey, Tseng Ling-Mi |
| Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2022 11 32 (12): 1568-1575. van Bommel Majke H D, Pijnenborg Johanna M A, van der Putten Louis J M, Bulten Johan, Snijders Marc P L M, Küsters-Vandevelde Heidi V N, Sweegers Sanne, Vos M Caroline, Ligtenberg Marjolein J L, Eijkelenboom Astrid, de Hullu Joanne A, Reijnen Casp |
| Chromosome instability region analysis and identification of the driver genes of the epithelial ovarian cancer cell lines A2780 and SKOV3. Journal of cellular and molecular medicine 2023 8 . Jianxiong Li, Zexin Chen, Wentao Xiao, Huaguo Liang, Yanan Liu, Wenqi Hao, Yongli Zhang, Fengxiang W |
| Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience. Journal of gynecologic oncology 2023 7 . Yoo-Na Kim, Yun Soo Chung, Ji Hyun Lee, Eunhyang Park, Seung-Tae Lee, Sunghoon Kim, Jung-Yun L |
| Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer. Cancer research 2023 12 . Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Yong Jae Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung-Tae Lee, Jung-Yun L |
| ARID1a Gene as a Potential Early Marker to Tackle Endometriosis-Associated Ovarian Cancer. Aging and disease 2023 11 . Pawel Kordowitzki, Sylvia Mechsner, Jalid Sehou |
| Ovarian Cancer Patient-Derived Organoids Used as a Model for Replicating Genetic Characteristics and Testing Drug Responsiveness: A Preliminary Study. Cell transplantation 2024 9 33 9636897241281869. Yu-Hsun Chang, Kun-Chi Wu, Kai-Hung Wang, Dah-Ching Di |
| Restoration of ARID1A Protein in ARID1A-deficient Clear Cell Carcinoma of the Ovary Attenuates Reactivity to Cytotoxic T Lymphocytes. Cancer genomics & proteomics 2024 6 21 (4): 414-420. Risa Tsunematsu, Aiko Murai, Yuka Mizue, Terufumi Kubo, Tasuku Mariya, Rena Morita, Kenji Murata, Takayuki Kanaseki, Tomohide Tsukahara, Yoshihiko Hirohashi, Tsuyoshi Saito, Toshihiko Torig |
- Page last reviewed:Feb 1, 2024
- Content source: